期刊文献+

不同细胞因子对脐血CD_(34)^+细胞扩增的影响 被引量:4

Effect of different cytokines on the proliferation of CD_(34)^+ hematopoietic cells in cord blood*
下载PDF
导出
摘要 目的探讨不同细胞因子促进脐血CD34+细胞扩增的效应,为下一步的临床应用奠定基础。方法采用EasySep免疫磁珠阳性选择系统分离脐血中CD34+细胞,在无血清、无基质细胞培养体系中添加不同细胞因子培养2周,分组:A组,SCF+FL+TPOB组,SCF+FL+TPO+IL-3C组,SCF+FL+TPO+G-CSF。结果CD34+细胞数目于培养后7d达到峰值,3组间差异无显著性;B组扩增至14d时细胞总数达(384.40±17.48)倍,显著高于另外2组。扩增7d后的脐血细胞经体外培养可形成造血集落。结论体外扩增脐血CD34+细胞理想的细胞因子组合为SCF+TPO+FL,以7d为宜。 [Objective] To investigate the proliferative effect of different cytokines on the CD34^+ hematopoietic cells in umbilical cord blood. [Methods] In this study, a serum-free, stroma-free medium for hematopoietic stem cells proliferation was systematically developed. CD34^+ cells isolated with the EasySep human CD34^+ positive selection system from umbilical cord blood were cultured in vitro with different cytokines for 14 days to evaluate proliferative potential. Group A: SCF+FL+TPO, group B: SCF+FL+TPO+IL-3, group C: SCF+FL+TPO+G-CSF. [Results] The number of CD34^+ cells reached peak at the 7th day with no significant difference among 3 groups. While addition of the growth factors SCF, TPO, FL and IL-3 to serum-free media did allow high proliferation of hematopoietic cells with the most total nuclear cells after 7 and 14 days of culture. CFU-G and CFU-GEMM formed after plantation of 7 d-proliferated cord blood hematopoietic cells into methylcellulose media. [Conclusions] These data indicate that SCF, FL and TPO can be used to efficiently proliferate hematopoietic progenitors from human umbilical cord blood.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2008年第1期61-64,共4页 China Journal of Modern Medicine
基金 国家科技部"863"计划重大专项资助课题(2003AA205080)
关键词 细胞因子 脐血 CD34 扩增 cytokine cord blood CD34 proliferation
  • 相关文献

参考文献12

  • 1ROCHA V, GLUCKMAN E. Eurocord and european blood and marrow transplant group. Clinical use of umbilical cord blood hematopoietic stem ceLls[J]. Biol Blood Marrow Transplant, 2006, 12(1): 34-41.
  • 2张洁霞,毛平.脐血CD34^+细胞及红系祖细胞扩增的实验研究[J].中国实验血液学杂志,2005,13(3):429-433. 被引量:5
  • 3蹇在伏,吴新华,陈方平,钟美佐,徐雅靖,刘弋,曹星玉.两种不同方法分离脐血造血干细胞实验研究[J].中国现代医学杂志,2004,14(19):68-69. 被引量:3
  • 4TSE W, LAUGHLIN MJ. Umbilical cord blood transplantation: a new alternative option[J]. Hematology, 2005, 1(2): 377-383.
  • 5UEDA T, TSUJI K, YOSHINO H, et aL Expansion of human NOD /SCID repopulafing cells by stem cell factor, Flk2 /Flt3 ligand, thrompolefin, IL-6, and soluble IL-6 receptor[J]. J Clin Invest, 2000, 105(7): 1013-1021.
  • 6YAO CL, CHU IM, HSIEH TB, et al. A systematic strategy to optimize ex vivo expansion medium for human hematopoietic stem cells derived from umbilical cord blood mononuclear cells[J]. Exp Hematol, 2004, 32(8): 720-727.
  • 7LEVAC K, KARANU F, BHATIA M. Identification of growth factor conditions that reduce ex vivo cord blood progenitor expansion but do not alter human repopulating cell function in vivo[J]. Haematologica, 2005, 90(2): 166-172.
  • 8ROSSMANITH T, SCHRODER B, BUG G, et al. Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of SCID repopulating cells[J]. Stem Cells. 2001. 19(4): 313-320.
  • 9王强,王冰,李荷莲,王巍.多种细胞因子在CD34^+细胞增殖分化中的作用[J].吉林大学学报(医学版),2004,30(2):250-252. 被引量:2
  • 10苏力,田丁,万岁桂,刘聪艳,徐娟.脐血CD34^+细胞体外短期培养扩增研究[J].首都医科大学学报,2002,23(3):218-221. 被引量:2

二级参考文献33

  • 1张洁霞,毛平.脐血CD34^+细胞及红系祖细胞扩增的实验研究[J].中国实验血液学杂志,2005,13(3):429-433. 被引量:5
  • 2Lu L, Xiao M, Shen RN, et al. Enrichment, characterization,and responsiveness of single primitive CD34 human umbilical cord blood hematopoietic progenitor with high proliferative and replating potential [J]. Blood, 1993, 81 (3): 41-48.
  • 3Hows JM, Marsh JC, Bradley BA, et al. Human cord blood:a source of transplantable stem cells [J] . Bone Marrow Transplant, 1992, 9 (Suppl) 1: 105-108.
  • 4Berardi AC, Wang A, Levine JD, et al. Functional isolation and characteriation of human hematopoietic stem cells [J].Science, 1995, 267 (6): 104-108.
  • 5Broxmeyer HE, Hangoc G, Copper S. Clinical and biological aspects of human umbilical cord blood as a source of transplantable hematopoietic stem and progenitor cells [J].Bone Marrow Transplant, 1992, 9 (Suppl 1): 7-10.
  • 6Laiuppaa JA, Papoutsakis ET, Miller WM. Evaluation of cytokines for expansion of the megakaryocyte and granulocyte lineages [J]. Stem Cells, 1997, 15 (3): 198-206.
  • 7Yoshida M, Tsuji K, Ebihara Y, et al. Thrombopoietin alone stimulates the early proliferation and survival of human erythroid, myeloid and multipotential progenitors in serumfree culture [J]. Br J Haematol. 1997, 98: 254-264.
  • 8Brozmeyer HE, Kurtberg J, Gluckman E. Umbilical cord blood hematopoietic stem and repopulating cells in human clinical translantation [J]. Blood Cells, 1991, 17: 313-329.
  • 9Denning-Kendall P, Donaldson C, Nicol A, et al. Optimal processing of human umbilical cord blood for clinical banking [J].Exp Hematol, 1996, 24: 1394-1401.
  • 10Bertolini F, Lazzari L, Lauri E, et al. Comparative study of different procedures for the collection and banking of umbilical cord blood[J]. J Hematother, 1995,4: 29-36.

共引文献13

同被引文献15

  • 1黄礼明,胡莉文,陈怡宏,丘和明.青蒿鳖甲汤对急性髓系白血病缓解期免疫功能的影响[J].辽宁中医杂志,2005,32(3):193-194. 被引量:17
  • 2李群良,蔡海波,刘启威,谭文松.脐血CD34^+造血干/祖细胞基因表达图谱的研究[J].中国免疫学杂志,2007,23(1):59-62. 被引量:3
  • 3俞松,刘文英,胡月光,唐耘熳,侯昉,刘鹏.Fas、bcl-2与移植血管瘤自然退化的动态研究[J].中华小儿外科杂志,2007,28(3):149-151. 被引量:7
  • 4陈超,杨体泉.婴幼儿血管瘤内皮细胞凋亡研究进展[J].实用儿科临床杂志,2007,22(11):869-871. 被引量:9
  • 5Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children:A classification based on endothelial characteristics [ J]. Plast Reconstr Surg, 1982,69 ( 3 ) :412 -422.
  • 6Razon MJ, Kraling BM, Mulliken JB, et al. Increased apoptosis coincides with onset of involution in infantile hemangioma [ J ]. Mircocirculation, 1998,5(2 -3) :189 - 195.
  • 7Zakeri Z,Lockshin RA. Ceil death:History and future[ J ]. Adv Exp Med Biol,2008 ,615 :1 - 11.
  • 8Lavrik IN, Golks A, Riess D,et al. Analysis of CD95 threshold signaling: Triggering of CD95 ( FAS/APO - 1 ) at low concentrations primarily resuits in survival signaling[ J ]. J Biol Chem, 2007,282 (18) : 1366d - 13671.
  • 9Mawji IA, Simpson CD, Hurren R, et al. Critical role for Fas - associated death domain - like interleukin - 1 - converting enzyme - like inhibitory protein in anoikis resistance and distant tumor formation [ J ]. J Natl Cancer Inst ,2007,99(10) :811 - 822.
  • 10Saulle E, Petronelli A, Pasquini L, et al. Proteasome inhibitors sensitize ovarian cancer cells to TRAIL induced apoptosis[ J]. Apoptosis ,2007,12 (4) :635 -655.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部